NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

NeuroTherapia is a private, pre-clinical stage biotechnology company developing novel therapies that decrease the neuroinflammation which plays a critical role in a wide spectrum of diseases such as neuropathic pain and Alzheimers disease.

NeuroTherapias therapeutic approach is based on research originating from the laboratory of co-founder Mohamed Naguib Attala, and the technologies he discovered and developed at the Cleveland Clinic.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.neurotherapia.com
Founded2015
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
10000 Cedar Avenue Ohio 44106
Cleveland
United States
Email
Contact Number
+1 216-870-7969

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/neurotherapia” connections=”true” suffix=””]

Sep 2016, NeuroTherapia Inc. has received an investment of $1.7 million from the Alzheimers Drug Discovery Foundation to advance its NTRX-07 drug toward human clinical trials.

Oct 2015, NeuroTherapia Cleveland Clinic spinoff company has raised $1 million in an effort to take on Alzheimers and other neurological diseases.